2.0
Feb 26, 2025
Current employee, less than 1 year
Bukarest,
Recommend
CEO approval
Business Outlook
Pros
Good salary Exposure to interesting studies
Cons
Management is in shambles and trying to keep a sinking ship afloat. No one likes working here. Everyone wants to leave (EU Country) FTE assignments are removed from reality and the company expects you to be assigned to 10 oncology studies. With 10 sites each. Non-existent benefits God-Complex Middle Managers.